VA Contract Exceeding Expectations, McKesson Says
This article was originally published in The Pink Sheet Daily
Executive Summary
The Department of Veterans Affairs supply contract is performing better than expected, McKesson CEO John Hammergren maintained during the Thomas Weisel Partners Healthcare Conference in Boston Sept. 9
You may also be interested in...
McKesson Takes Over VA Contract From AmerisourceBergen May 10
ABC said it does not plan to appeal a judge’s ruling upholding the Department of Veterans Affairs’ selection. Beginning April 1, Amerisource will service VA at a price of cost minus 5% – McKesson’s winning bid – until McKesson takes over.
Is The Opioid REMS Too Big To Study?
US FDA’s workshop to discuss new ideas to assess the impact of the opioid REMS comes after the industry collaboration behind the REMS has deemed the task essentially impossible.
Growing Pains For US FDA Oversight Of Opioids: Starting Over On Assessment Of REMS
Whether CME for pain management has the intended impact on prescribing is likely focus of new ‘suite of studies’ intended to assess the opioid REMS program. The challenges for FDA include teasing out the impact of the risk management program amid all the other public health efforts on opioids.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: